APA aipamena

(2000). Survival in renal cell carcinoma: A randomized evaluation of tamoxifen vs interleukin-2, α-interferon (leucocytic) and tamoxifen – reply. Nature Publishing Group.

Chicago Style aipamena

Survival in Renal Cell Carcinoma: A Randomized Evaluation of Tamoxifen Vs Interleukin-2, α-interferon (leucocytic) and Tamoxifen – Reply. Nature Publishing Group, 2000.

MLA aipamena

Survival in Renal Cell Carcinoma: A Randomized Evaluation of Tamoxifen Vs Interleukin-2, α-interferon (leucocytic) and Tamoxifen – Reply. Nature Publishing Group, 2000.